Key Takeaways

• Yes — a California telehealth practice that renders clinical services requires a professional corporation. LLCs are barred from rendering professional services under Cal. Corp. Code § 17701.04, and “telehealth” doesn’t change that. The entity is a medical PC, nursing PC, or other discipline-specific PC just as it would be for an in-person practice.
• California is NOT a member of the Interstate Medical Licensure Compact (IMLC) or the Nurse Licensure Compact (NLC). A telehealth practice with patients in California must have providers individually licensed in California, and a California-based platform reaching patients in other states needs separate licensure in each of those states.
• Telehealth is regulated under B&P Code § 2290.5, which defines telehealth, sets informed-consent rules, and applies the same standard of care as in-person practice.
• AB 3030 and AB 489 are now in effect for AI use in California healthcare. AB 3030 requires disclosure when generative AI generates patient clinical communications. AB 489 (effective January 1, 2026) prohibits AI systems from misrepresenting themselves as licensed practitioners.
• DEA telemedicine flexibilities for controlled substances are extended through December 31, 2026 under the Fourth Temporary Extension. Permanent DEA rules are still pending. Plus two final rules (buprenorphine for OUD and VA continuity of care) took effect December 31, 2025.

The Short Answer

If you’re starting or scaling a California telehealth business that delivers clinical services, you need a professional corporation. The entity type tracks the practice — a physician-led platform organizes a medical corporation; an NP-led platform organizes a nursing corporation. Either way, an LLC is not an option.

Telehealth doesn’t change the entity rules. It changes the operational rules around licensure, informed consent, technology, and prescribing — and those operational rules are where compliant platforms separate themselves from the ones that get cease-and-desist letters.

Quick CTA: If you’re building a California telehealth business — physician-led, NP-led, multi-state, or a tech-and-clinical hybrid — the entity-and-structure conversation needs to happen before you sign payor contracts, raise capital, or onboard patients. Bay Legal, PC counsels healthcare entrepreneurs on telehealth corporate structure, MSO design, and the 2026 California AI rules. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

Can You Run a California Telehealth Practice as an LLC? (No.)

Five statutes converge on the answer:

• Corp. Code § 13401(b) confines the rendering of “professional services” — those requiring a license under the Business & Professions Code, the Chiropractic Act, or the Osteopathic Act — to a professional corporation organized under the Moscone-Knox Professional Corporation Act.
• Corp. Code § 17701.04 prohibits LLCs from rendering professional services unless a licensing statute expressly authorizes it. No California licensing statute authorizes LLCs to render medical, nursing, or other clinical telehealth services.
• B&P Code § 2290.5 treats telehealth as a modality for delivering health care services, not a separate professional practice. The clinician still has to be appropriately licensed and the corporation still has to be appropriately structured.
• B&P Code § 2052 prohibits unlicensed practice of medicine — a statute that captures both individual and corporate violations.
• B&P Code § 2400 declares that corporations have no professional rights to practice medicine. This is the Corporate Practice of Medicine (CPOM) doctrine, and it applies to telehealth identically to how it applies to in-person practice.

The practical upshot: an LLC that purports to deliver clinical telehealth in California is non-compliant from day one, regardless of whether the platform is California-based or merely reaching California patients from another state.

What Entity Does a Telehealth Practice Need?

The entity tracks the clinical profession. For most California telehealth businesses, that means one of these:

Telehealth practice type	California entity required	Authority
Physician-led primary care or specialty	Medical corporation	Cal. Corp. Code § 13401.5(a); B&P §§ 2052, 2400
NP-led practice (traditional, 103 NP, or 104 NP)	Nursing corporation	Cal. Corp. Code § 13401.5(f); B&P Code § 2837 series
Psychology / therapy platform	Psychological, MFT, or LCSW corporation	Cal. Corp. Code § 13401.5(c), (g), (h)
Multidisciplinary medical platform (with physician majority + NP/PA/other minority)	Medical corporation with physician 51%+	Cal. Corp. Code § 13401.5(a)

Two structural notes the writing team should land:

• A “telehealth platform” is not a recognized entity type in California. The same medical, nursing, or other professional corporation rules apply.
• A telehealth platform that wants to bring in lay capital — venture funding, private equity, technology investors — typically uses the friendly-PC + MSO model: a physician-owned PC delivers clinical services, and a separate (lay-owned) MSO provides administrative services under a management services agreement. We cover the MSO/PC architecture in detail elsewhere. [suggested internal link: practice area page on Healthcare MSO and Management Structures]

California Telehealth Statute: B&P Code § 2290.5

The core California telehealth statute is B&P Code § 2290.5. It does five things:

1. Defines telehealth as “the mode of delivering health care services and public health via information and communication technologies to facilitate the diagnosis, consultation, treatment, education, care management, and self-management of a patient’s health care,” including both synchronous interactions and asynchronous store-and-forward transfers.
2. Requires informed consent before the initial telehealth encounter — verbal or written, documented in the patient’s record.
3. Applies the same standard of care to telehealth as to in-person practice. The clinician is judged on the same professional standard.
4. Authorizes licensed clinicians to use telehealth for any service they could otherwise provide in person, subject to standard of care.
5. Addresses hospital privileges (§ 2290.5(h)) so that originating-site hospitals may accept the privileges and credentials of distant-site providers.

A clinician practicing under § 2290.5 must be licensed in the state where the patient is located at the time of the encounter, not where the clinician is located. That’s the multi-state issue we get to next.

Multi-State Licensure: California’s Hard Stance

California is one of the few large states that has not joined either of the major multi-state licensure compacts as of May 2026.

• Interstate Medical Licensure Compact (IMLC): Authorizes expedited multi-state licensure for physicians. As of 2026, 40+ states, plus the District of Columbia and Guam, are members. California is not a member. Physicians who want to treat California patients via telehealth must obtain a California medical license through the standard Medical Board of California process.
• Nurse Licensure Compact (NLC): Authorizes a multistate license for RNs and LPNs. 40+ states are members. California is not a member. Nurses treating California patients via telehealth must hold a California RN license. The APRN Compact, which would do something similar for nurse practitioners, has been adopted by a smaller number of states; California has not joined.

The operational consequences for a California-based telehealth platform are:

• Reaching California patients: every clinician on the platform needs an active California license in their discipline.
• Reaching out-of-state patients: each clinician needs a license in each state where they’re treating patients. The IMLC streamlines this for physicians in 40+ states, but California physicians can’t use the IMLC as their state of principal license.
• Scaling to multi-state: the entity question multiplies. Each state typically requires its own professional corporation (or analogous entity) for clinicians licensed in that state. Many telehealth companies operate a separate “friendly PC” in each state, each owned by a physician licensed there, with a single MSO providing administrative services across all of them.

California’s interstate-compact status can change with new legislation, and bills have been introduced in past sessions. Confirm California’s IMLC, NLC, and APRN Compact membership before relying on any specific multi-state structure; the IMLC’s and NLC’s own websites maintain current member lists.

Mid-content CTA: If your telehealth platform is reaching patients in multiple states — or planning to — the state-by-state entity architecture is often a major source of compliance friction. Bay Legal, PC works with telehealth founders, investors, and CMOs on multi-state PC formation, MSO design, and the underlying contracts. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

How CPOM Applies to Telehealth Platforms

The Corporate Practice of Medicine doctrine doesn’t soften because the practice is virtual. If anything, telehealth platforms are the leading edge of how CPOM gets enforced in California in 2026.

The doctrine’s core rule, from B&P § 2400 and decades of Medical Board guidance, is that non-physicians cannot:

• Employ physicians for the purpose of practicing medicine.
• Control clinical decisions, including diagnostic test selection, referrals, prescriptions, treatment plans, panel size, and clinical hours.
• Own patient medical records (these belong to the practice).
• Set parameters that constrain a physician’s clinical judgment.

A telehealth platform that hires physicians as W-2 employees of the platform itself, while the platform is owned by venture investors, runs head-on into CPOM. The standard compliant structure for telehealth investment in California has three layers:

1. A physician-owned “friendly” professional corporation (PC). This PC employs (or contracts with) all clinicians and delivers all clinical services. At least 51% of its shares are held by California-licensed physicians (with NPs and other allied professionals as minority shareholders if needed under § 13401.5(a)).
2. A management services organization (MSO). This entity, which can be lay-owned (LLC or corporation), provides the platform technology, billing, marketing, scheduling, HR, compliance, and operational infrastructure.
3. A Management Services Agreement (MSA) between the PC and the MSO. The MSA defines the services the MSO provides, the management fees, and — critically — preserves all clinical decisions, panel control, prescribing, and clinical hiring decisions to the PC. An MSO that exercises clinical control violates CPOM regardless of how the contract is drafted.

SB 351 (Cortese, Ch. 409, Stats. 2025) — effective January 1, 2026 — codifies these CPOM principles specifically against private equity groups and hedge funds engaging with physician and dental practices. SB 351 voids non-compete and non-disparagement clauses in many MSO/asset-purchase agreements between PE/hedge funds and physician practices, prohibits clinical control by PE owners, and authorizes the California Attorney General to enforce these rules.

AB 1415 (Bonta, Ch. 641, Stats. 2025) — also effective January 1, 2026 — added MSOs, PE groups, hedge funds, and certain other entities to the “noticing entities” required to file pre-transaction notices with the Office of Health Care Affordability (OHCA) at least 90 days before covered material change transactions.

These two bills tightened the rules around the MSO/PC model. They didn’t ban it. A well-structured friendly-PC-plus-MSO arrangement remains a common California telehealth scaling structure — but the contract terms, governance, and notice obligations need to be drafted with SB 351 and AB 1415 in mind. OHCA’s implementing regulations for AB 1415 continue to develop; confirm current status at hcai.ca.gov before relying on specific procedural steps.

DEA Controlled Substance Prescribing via Telehealth (2026 Status)

Federal law controls the prescription of controlled substances. The relevant statute is the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (codified at 21 U.S.C. §§ 802(54), 829), which requires (with limited exceptions) at least one in-person medical evaluation before a DEA-registered practitioner can prescribe a controlled substance via the internet.

Since March 2020, DEA has used a series of temporary rules to relax that requirement, allowing telemedicine prescribing of Schedule II–V controlled substances without a prior in-person visit. The current state of play as of May 2026:

• Fourth Temporary Extension (effective December 31, 2025): extends COVID-era telemedicine prescribing flexibilities through December 31, 2026. Allows DEA-registered practitioners to prescribe Schedule II–V controlled substances via telemedicine without a prior in-person evaluation, subject to conditions in 21 CFR 1307.41.
• Expansion of Buprenorphine Treatment via Telemedicine Encounter (effective December 31, 2025): permanent rule allowing audio-only and audio-video telemedicine prescribing of buprenorphine for opioid use disorder without a prior in-person evaluation, under specified conditions. Codified at 21 CFR 1306.51.
• Continuity of Care via Telemedicine for VA Patients (effective December 31, 2025): permanent rule allowing VA practitioners to prescribe controlled substances to VA patients via telemedicine without a prior in-person evaluation, under specified conditions. Codified at 21 CFR 1306.52.

DEA has signaled that a comprehensive permanent rule — with special-registration requirements for telemedicine prescribing — remains in development, but no final permanent rule had been issued as of the time this article was prepared. Telehealth platforms relying on the controlled-substance flexibilities should plan for tighter rules in the future, which are likely to include some combination of prescription drug monitoring program checks, audio-video technology requirements, Schedule II restrictions, identity verification, and DEA data reporting. This area has been changing on a rolling basis with new DEA rulemaking; confirm the current status of any DEA telemedicine flexibilities and any new rulemaking activity at deadiversion.usdoj.gov before relying on specific authorities.

In addition to the federal layer, California has its own controlled-substance prescribing rules under the CURES prescription drug monitoring program and Health & Safety Code Division 10. Telehealth platforms prescribing controlled substances in California must enroll in CURES and follow California prescribing rules independently of the DEA requirements.

[suggested internal link: practice area page on Healthcare Regulatory Compliance]

California AI Rules That Now Reach Telehealth

Two California laws govern AI use in healthcare communications, both relevant to telehealth platforms that use generative AI:

AB 3030 (Calderon, Ch. 879, Stats. 2024) — effective January 1, 2025

Codified at Health and Safety Code § 1339.75. Requires any health facility, clinic, physician’s office, or group practice using generative AI to generate written or verbal patient communications containing “patient clinical information” to include:

1. A disclaimer that the communication was generated by GenAI.
   • In written physical or digital communications (letters, emails): prominently at the beginning of each communication.
   • In continuous online interactions (chat-based telehealth): prominently displayed throughout.
   • In audio communications: provided verbally at the start and end.
2. Clear instructions on how the patient can contact a human health care provider.

Key exemption: AB 3030 does not apply to AI-generated communications that are read and reviewed by a licensed or certified human health care provider before being sent. This is the safe harbor most telehealth platforms rely on — but the review has to be substantive, not a rubber stamp.

The law also does not apply to administrative communications (appointment scheduling, billing, check-up reminders) — only to communications about a patient’s clinical information.

AB 489 (Bonta, Stats. 2025) — effective January 1, 2026

Adds Chapter 15.5 (commencing with § 4999.8) to Division 2 of the Business and Professions Code. Prohibits AI systems — and the persons or entities that develop or deploy them — from using terms, letters, phrases, or design elements (post-nominal letters like “MD” or “RN,” titles, icons, conversational tone) that indicate or imply that the AI is licensed to practice a health care profession, or that the care being offered is being provided by a licensed practitioner, unless that’s actually true.

For a telehealth chatbot, the practical implications are:

• AI cannot identify itself as “Doctor [Name],” use “M.D.” or other licensure post-nominals, or otherwise present itself as a licensed clinician.
• Marketing copy describing the AI as “doctor-level,” “clinician-guided,” or “expert-backed” needs documented licensed-practitioner involvement to support those claims.
• Each violation can be treated as a separate offense enforceable by the relevant licensing board.

AB 489 enforcement guidance from the Medical Board, BRN, and other healing arts boards is still developing; the writing team should check each board’s website for any newly-issued guidance before publication.

A telehealth platform that uses AI to triage patients, draft messages, or interact directly with users needs to design the AI interactions to satisfy both AB 3030 (disclaimers when AI generates clinical content without human review) and AB 489 (no licensure misrepresentation). The two statutes work together: AB 3030 governs what AI says about content, AB 489 governs what AI says about itself. Importantly, simply mentioning AI somewhere on the platform does not satisfy AB 3030’s disclosure requirement — the statute requires a specific disclaimer in the right form and place (prominent at the beginning of written communications, throughout continuous online interactions, verbally at the start and end of audio communications) plus clear instructions on how to reach a human provider. Platforms relying on the human-review safe harbor need actual substantive review, not a rubber stamp.

What Contracts and Documents a Compliant Telehealth Platform Needs

A non-exhaustive list, scaling with the platform’s size and complexity:

• Articles of Incorporation (ARTS-PC) for each professional corporation in each state where the platform operates.
• Bylaws with Moscone-Knox-compliant share-transfer provisions for each California PC.
• Statement of Information (SI-550) for each California PC.
• Management Services Agreement (MSA) between the PC(s) and the MSO. The MSA defines services, fees, terms, and critically preserves clinical authority to the PC. Post-SB 351 and AB 1415, the MSA terms get more attention than they used to. [suggested internal link: practice area page on Management Services Agreements]
• Provider Services Agreements between the PC and each clinician (W-2 employment or 1099 independent contractor).
• Patient-facing terms of service and informed consent documents satisfying B&P § 2290.5 and any state-specific telehealth informed consent rules.
• HIPAA Notice of Privacy Practices and HIPAA Business Associate Agreements with every technology vendor that touches protected health information.
• AB 3030 / AB 489 AI disclosures and policies, including disclosure templates, human-review protocols, and AI-system documentation.
• State-specific informed consent forms for each state where the platform operates.
• Payor enrollment and contracts for each state’s commercial and government payors.
• CURES enrollment for any California prescriber on the platform.
• DEA registration for prescribers handling controlled substances, plus internal protocols for the Ryan Haight / Fourth Temporary Extension requirements.
• OHCA notice protocols if the platform’s MSO arrangement triggers AB 1415 noticing obligations.

This is not a list any telehealth founder can knock out in a weekend. The compliance scaffolding takes weeks to build out properly and months to maintain at scale.

Common Pitfalls and Red Flags

1. Forming an LLC in California for clinical telehealth services.
2. Using a single PC to deliver services in multiple states — most states require their own PC.
3. Treating the friendly PC as a formality rather than a real corporate governance arrangement (this is the structural failure that draws SB 351 enforcement attention).
4. Lay-owned platform employing physicians directly to deliver clinical services — straight CPOM violation.
5. AI-driven chatbots that imply licensed-clinician involvement without it — direct AB 489 violation.
6. Generative AI patient communications without AB 3030 disclaimers or substantive human review.
7. Prescribing controlled substances via telehealth without DEA registration or without following the Fourth Temporary Extension conditions.
8. Skipping CURES enrollment for California prescribers.
9. Missing the 90-day OHCA notice when a covered material change transaction triggers AB 1415.
10. Using out-of-state clinicians to treat California patients without California licensure.

Talk to a California Telehealth Attorney

California telehealth law in 2026 is not the same telehealth law it was in 2022. The friendly-PC-plus-MSO model is still the standard scaling structure, but SB 351 and AB 1415 reshaped the contract terms and oversight obligations. AB 3030 and AB 489 layered specific AI compliance requirements on top of the existing rules. And the multi-state expansion question is harder for California-based platforms than it is for IMLC-state platforms, since California-licensed physicians can’t use the compact to reach into other states.

If you’re building, scaling, or restructuring a California telehealth business, attorneys at Bay Legal, PC counsel telehealth founders, investors, and chief medical officers on entity structure, MSO design, multi-state expansion, AB 3030 and AB 489 AI compliance, DEA controlled-substance prescribing, and OHCA notice. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

[suggested internal link: contact / schedule a consultation page] — anchor in closing CTA

Frequently Asked Questions

Can I run a California telehealth business as an LLC?

No. Cal. Corp. Code § 17701.04 bars LLCs from rendering professional services. A California telehealth business that delivers clinical services must use a professional corporation — a medical corporation, nursing corporation, or other discipline-specific PC depending on the licensure of the providers.

Does a telehealth platform need a separate entity in each state?

In most cases, yes. Each state has its own professional-corporation rules and most require licensed practice through a state-specific entity. Many telehealth platforms operate a separate friendly PC in each state where they have providers and patients, with a single MSO providing administrative services across all of the PCs.

Is California a member of the Interstate Medical Licensure Compact?

No. As of 2026, California is not a member of the IMLC. Physicians treating California patients via telehealth must obtain a California medical license through the standard Medical Board of California process. California also is not a member of the Nurse Licensure Compact.

Can a California telehealth physician prescribe controlled substances without an in-person visit?

Through December 31, 2026, yes — under the DEA’s Fourth Temporary Extension of COVID-19 telemedicine flexibilities. A DEA-registered practitioner can prescribe Schedule II–V controlled substances via telemedicine without a prior in-person evaluation, subject to specified conditions. Two permanent rules (buprenorphine for OUD and VA patients) also took effect December 31, 2025. Permanent comprehensive DEA telemedicine rules are still pending.

What does AB 3030 require for telehealth platforms using AI?

AB 3030 (effective January 1, 2025, codified at Health & Safety Code § 1339.75) requires healthcare entities using generative AI to generate written or verbal patient communications about clinical information to include both a disclaimer that the communication was AI-generated and clear instructions for contacting a human provider. Communications reviewed and approved by a licensed health care provider before being sent are exempt. Administrative communications (scheduling, billing) are also exempt.

This article provides general information about California law and is not legal, tax, or financial advice. Reading this article, contacting Bay Legal, PC, or sending information through baylegal.com does not create an attorney-client relationship. The information here focuses on California law and may not reflect the law of other jurisdictions. Statutes, regulations, agency guidance, and case law change; this article reflects the authors’ understanding as of the date of publication and may not reflect later developments. For advice about your specific situation, consult a licensed California attorney.